Recommendations

Dr. M’s Women and Children First Podcast #80 – Deborah Tate, PhD – Studying the Obesity Epidemic

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

 

Obesity and Change – The Tech Intersection

Welcome to the podcast! Today, I am thrilled to host Dr. Deborah Tate, a distinguished professor in the Department of Nutrition at the University of North Carolina in Chapel Hill, with joint appointments in Health Behavior and Nutrition. She also holds a faculty appointment at the Nutrition Research Institute in Kannapolis, North Carolina where she explores innovative approaches to improve lifestyle behaviors that impact obesity, diabetes, and chronic disease risk. Dr. Tate is a behavioral scientist, receiving her Ph.D. in Clinical Psychology at Virginia Tech. Her research focuses on two main areas: (a) strategies for improving both short and long-term body weight regulation to reduce disease risks and (b) the development and translation of programs as alternatives to clinic-based care using digital and wearable technologies. She is known internationally for her work has published many papers in major nutrition and medical journals. Her work spans the intersection of behavioral health and obesity whereby she is a pioneer in digital health interventions. Her work has been pivotal in developing digital tools and online programs that support sustainable health changes, making access to wellness resources more inclusive and effective.

Dr. Tate has been at the forefront of harnessing technology to create lasting change, blending behavioral science with digital advancements to empower individuals and families to make improved choices. Her contributions have transformed how we think about health interventions in today’s digital age, offering scalable solutions that reach beyond traditional boundaries. Get ready for an insightful conversation with Dr. Tate as we dive into the science and the potential of digital health to foster resilience and well-being.

Enjoy,

Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 14 Issue 38

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Section I

Are Smart Phones a benefit or a curse for the teenager in school? This is becoming a huge topic this past year or so. Logic would seem to dictate that this is a curse more than a benefit, but what does the data and expert opinion show?

The Scientific American article “Do Phone Bans Help Students Perform Better in School?” examines the growing trend of banning smartphones in schools to enhance student performance and well-being. Numerous U.S. cities, including New York and Los Angeles, have recently implemented or are considering bans on phones in classrooms. Schools use tools like the Yondr pouch, which locks phones away during school hours, to enforce these bans. These measures are popular with educators and parents, with 60% of likely voters in New York State supporting such restrictions. Charlotte Schools has this policy: “In accordance with Charlotte-Mecklenburg Schools Student Code of Conduct, personal technology devices, including cell phones must remain off and put away during school hours. Violations will result in confiscation of the personal technology device. The district is not responsible (monetary value or replacement) for theft, loss or damage to personal technology or other electronic devices brought onto CMS property.” (CMS) My informal poll has a higher number of parents interested in phone ban restrictions in North Carolina….plus a section on teen anxiety.

Enjoy,

Dr. M

Dr. M’s Women and Children First Podcast #77 – Colleen Cutcliffe, PhD – Microbes and Health

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

This weeks guest is Dr. Colleen Cutcliffe.

Dr. Colleen Cutcliffe is a researcher and a thinker with persistence. Throughout history, these are the human qualities that lead people to develop amazing products and lead projects for the world to benefit from. Her story is one of discovery, passion and caring.

Dr. Cutcliffe holds a Ph.D. in Biochemistry and Molecular Biology from Johns Hopkins University and a B.A. in Biochemistry from Wellesley College. Her scientific background is complemented by her experience in managing both research and operations teams in the biotech sector. Before founding Pendulum Therapeutics, she held senior positions at Pacific Biosciences and Elan Pharmaceuticals, where she was instrumental in developing various technological platforms. She is the co-founder and CEO of Pendulum Therapeutics, a biotechnology company focused on developing innovative solutions to improve gut health through microbiome-based interventions. With over 20 years of experience in the biotechnology industry, Dr. Cutcliffe has become a recognized leader in microbiome science, applying her expertise to bridge the gap between cutting-edge research and practical, consumer-facing health solutions. At Pendulum Therapeutics, Dr. Cutcliffe has led the development of novel probiotic formulations specifically designed to address metabolic diseases like type 2 diabetes. Her work has been pivotal in the growing recognition of the microbiome’s role in human health, pushing forward the concept of targeted probiotics as a potential therapeutic option. Under her leadership, Pendulum Therapeutics has gained recognition for its scientific rigor and innovative approaches to personalized nutrition.

Today, we discuss the story of her discovery and the fact that her work is the beginning of a hopeful wave of change for humans through gut microbiome manipulation. Dr. Cutcliffe helps us understand the basics of the microbiome, what helps it stay balanced and conversely, what upsets it. How does it support our metabolism and health in general. The main thrust of her work comes into the spotlight with Akkermansia mucinophilia, a keystone species for positive health.

Please Enjoy my conversation with Dr. Cutcliffe,

Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 13 Issue 49

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Respiratory Syncytial Virus
RSV is a 150 nanometer RNA virus that comes from a human orthopneumovirus that circulates in the winter primarily. Young children and infants infected with RSV mostly have upper respiratory tract symptoms where a subset develop lower respiratory tract disease known as bronchiolitis with the primary infection. It is the most common reason for hospitalization in infants between 0 and 6 months of age. Bronchiolitis appears as a wheezy, cough centric illness that rarely may progress to increased respiratory effort noted by wheezing, rales (lung crackles – sounds like stepping on leaves), chest wall rib retractions, grunting, fast breathing, nasal flaring and eventually respiratory hypoxia. If it persists, the event can rarely lead to respiratory collapse and death. Annually, 150 children under 5 years of age die from RSV in the US. Most of these children are premature births and have cardiopulmonary disease issues. Term healthy children rarely succumb to RSV in a serious way. A recent study of German infants and children hospitalized with RSV identified these risk factors: age <6 months, birth at 28–37 weeks gestational age, congenital defects, perinatal respiratory and cardiovascular disorders, and various other comorbidities as significant risk factors for ICU admission and death. ( Cai et. al. 2020) plus a mini lit review and a discussion on thanksgiving.
Enjoy
Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 13 Issue 45

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Nature Deprivation Disorder: As we are getting closer to the end of the year and the cold strikes us hard in the face, we have a tendency to hunker down indoors and avoid the outside. Video games and screens are omnipresent in many of our children’s lives. They pervade their thoughts. They significantly limit their self-driven need and desire to explore, imagine and be present with nature, silence and life as it exists around them. Nature and natural actions are some of the best teachers of rational action and normalcy in any ecosystem….Autism etiology and a recipe round out the week.

Enjoy,

Dr. M

Dr. M’s SPA Newsletter Audiocast Volume 13 Issue 21

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Literature review this week: Plastics in the blood, dogs can sniff Covid, mental health and exercise, CT scans and brain cancer risk, aging and the microbiome. Also, a piece on mothers and the shaming from social media critics. Recipe is coconut curry fish.

For example: Brain Cancer – a single CT can raise the risk of cancer of the brain in children if the exposure occurs before age 22 years.

Enjoy,

Dr. M

Dr. M’s Women and Children First Podcast #39 Paul Offit, MD – Latest Information of Vaccines for Covid and Children

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Podcast: Play in new window | Download

Subscribe: Email | RSS | More

Dr. Paul A. Offit is Director of the Vaccine Education Center and professor of pediatrics in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania.

Dr. Offit is an internationally recognized expert in the fields of virology and immunology, and was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention. He is a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee, a member of the Institute of Medicine and co-editor of the foremost vaccine text, Vaccines.

He is a scientist, a skeptic, a thinker and an individual deeply passionate about children’s health.

This week we sit down again to discuss the latest with Covid, vaccines and children’s health as new data has prompted a new discussion.

I hope that you enjoy my latest conversation with Dr. Offit,

 

Dr. M

1 2 … 7